Posted in | News | Plastics and Polymers

BASF Make Progress in SE Conversion

The conversion of BASF Aktiengesellschaft into a European Company (Societas Europaea, SE) has reached a further milestone: On June 12, the special negotiating body of employees (SNB) held the constituent meeting in Heidelberg, Germany. The 29 European employee representatives of BASF voted for Robert Oswald, chairman of the central works council, to chair the SNB.

At its meeting, the SNB established a twelve-man negotiating committee, comprising representatives from Belgium, Germany, France, Great Britain, Italy, Poland, Spain as well as an executive representative. The committee will negotiate an employee participation agreement with representatives of the company’s management by no later than November. Hans-Carsten Hansen, President Human Resources at BASF is chief negotiator for the management board of BASF. The agreement governs issues such as cross-border information for and consultation of employees as well as their participation on the supervisory board.

BASF plans to complete the conversion into a SE in the first quarter of 2008 after concluding negotiations with the special negotiating body of employees.

BASF is the world’s leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics, performance products, agricultural products and fine chemicals to crude oil and natural gas. As a reliable partner to virtually all industries, BASF’s high-value products and intelligent system solutions help its customers to be more successful. BASF develops new technologies and uses them to meet the challenges of the future and open up additional market opportunities. It combines economic success with environmental protection and social responsibility, thus contributing to a better future. BASF has approximately 95,000 employees and posted sales of €52.6 billion in 2006. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA), New York (BF) and Zurich (AN).

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.